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This article discusses the importance of the role of the health visitor in the containment of 
Antimicrobial Resistance, focusing on three key areas of practice. Antimicrobial resistance is 
a huge public health problem and all health professionals should be engaged in preserving 
antibiotics for future generations. The focus of this article will discuss the health visitor’s 
role in infection prevention and control, antibiotic stewardship and prescribing, and 
improving public engagement and professional development in antibiotic stewardship and 
Infection Prevention and Control. 
 
Introduction to Antimicrobial Resistance 
Antimicrobial resistance (AMR) occurs when a microbe mutates or acquires genetic 
information from another microbe, making it resistant to antibiotics. There are many 
contributing factors, one being antibiotic use in humans, most of which are prescribed in 
primary care (74%) (English surveillance programme for antimicrobial utilisation and 
resistance (ESPAUR) 2016). In addition, a recent prevalence survey in Scotland 
demonstrated that around one in three hospital patients are on at least one antibiotic at 
any one time (Health Protection Scotland (HPS) 2017). Antimicrobial Resistance is also 
related to antibiotic use in animals, including farming and food production, and the 
environment (Michael et al 2014). In essence it is Darwin’s theory of evolution, the “survival 
of the fittest”, occurring at a microbe level. This makes AMR difficult to see and 
conceptualise and there have been recent calls for better communication and language 
about AMR for healthcare professionals, and the public (Mendelson et al 2017). It is very 
important that the risk is understood and this article focuses specifically on the need for 
health visitors to be engaged in the agenda of containing AMR. 
 
The Burden of Antimicrobial Resistance 
Antimicrobial Resistance has been declared one of the greatest threats to global health 
(WHO 2016a) on the basis of the ‘3 Ds’ of public health: distress, disability and death. It is 
the cause of an estimated 700 000 deaths per year globally and, in the European Union 
alone it is estimated to cost 1.5 billion Euros in healthcare and productivity losses (European 
Commission 2017). The response to this requires international effort as resistant organisms 
know no country borders, do not have to go through security control, and are therefore 
easily imported from one country to another. The World Health Organisation (WHO 2017a), 
this year, published a list of the priority AMR pathogens, some of which were classed as 
being critical threats (see Table 1). As might be expected it is the healthcare associated 
pathogens which feature as critical, predominantly gram negative bacteria, and it is this 
current threat that we should be concerned about in the United Kingdom (UK). However, 
there are also community specific threats, as detailed in the high and medium priorities, 
which mean a population effort is required to contain AMR. 
Given the international threat of AMR, the UK government commissioned Lord O’Neil to 
carry out a review to examine the economics of AMR for the G7, inclusive of projections of 
the impact if nothing was done to contain the threat (O’Neil 2016). The review pointed to 
what might happen if we do not control AMR and estimated that we would return to a pre-
antibiotic era with a 43% attributable mortality, resulting in 10 million deaths worldwide by 
2050. This estimated mortality was greater than any other disease including cancers, road 
traffic accidents and diarrhoeal illness. As a result of this, the Chief Medical Officer (CMO) 
from the UK government, said it was “arguably as important as climate change” (CMO 2011) 
and it was placed on the UK risk register. Whilst the O’Neil report has been criticised for 
oversimplifying the costs and being based on very limited evidence (de Kraker et al 2016) it 
should be noted that it was only based on three of the critical types of AMR and is thus an 
underestimate of all AMR impact.  
A new global call to action from the G7, and other key international organisations such as  
WHO and the World Economic Forum (WEF 2017), arose from this work and from nursing 
leadership as a key policy area (Hughes 2016; Royal College of Nursing (RCN) 2014). This 
literature points to the role that nurses and midwives should play in reducing the risk of 
AMR, and relates specifically to the national and international action plans developed by 
many countries in response to the problem. The UK AMR action plan (Department of Health 
(DoH) 2013) has seven action areas (detailed in Table 2). Action areas one to three are 
where health visitors, in their day to day interactions and role, can support this agenda and 
so will be the focus of the remainder of this article. 
Actions for Health Visitors in Containing AMR  
There are three main action areas for health visitors in contributing to the containment of 
AMR. The first is improving infection prevention and control (IPC) in human health, the 
second is antibiotic stewardship and prescribing and the third is improving public 
engagement and professional development in antibiotic stewardship and IPC. Each of these 
will now be addressed in turn. 
 
Action area 1 for health visitors: Improving infection prevention and control in human 
health (IPC and vaccination) 
Preventing infections in the population 
Preventing the infection from occurring in the first place is the best way to preserve the use 
of antibiotics and save patients from distress caused by infections. Respiratory and 
gastrointestinal infections are a major cause of childhood illness, with poor respiratory 
etiquette and hand hygiene contributing to increased spread. The consequences and impact 
of these infections in children and young people have far-reaching implications, including 
school absences, spread of infection to other family members and therein sickness absence 
from work. Health visitors have a fundamental role in health protection. Helping children, 
parents and the wider family to understand the importance of hand hygiene in protecting 
their own health and that of their family and friends is key. The same responsibility also lies 
with us all, as professionals. 
We have a professional responsibility to employ standard infection control precautions for 
every patient or child, every time, to prevent the potential risk of infection transmission 
(National Health Service, National Services Scotland (NHS NSS) 2012). Practices such as hand 
hygiene, safely managing waste and sharps, risk assessment and use of personal protective 
equipment such as gloves, are fundamental to health visiting practice. It sounds easy to do 
but even the simplest, most important measure, namely hand hygiene, is not carried out 
optimally. The WHO (2017b) organised the world hand hygiene day campaign this year on 
the 5th May with a call to action to: ‘clean hands, save lives and contain AMR’. This is 
because even when healthcare workers in high income countries are trained in the 
technique for hand hygiene, have the instructions in front of them, and know they are being 
watched for the purposes of a study, they only comply 65% of the time. This indicates that 
behavioural factors are important in the improvement of hand hygiene (Reilly et al 2016).  
Demonstrating appropriate hand hygiene, during home visits and clinic appointments can 
change behaviour through role modelling. There may also be the opportunity to discuss 
infection prevention measures in greater detail when there is a specific need, for example, 
during outbreaks, after administering a live vaccine or if there is a recurrence of infection 
e.g. worms.  
The importance of vaccination 
Dispelling the myths of vaccination is the second area of focus for heath visitors. The WHO 
(2017c) have produced very helpful evidence based question and answer information to 
dispel the current myths on safety, immunity, multiple vaccination at one time, 
preservatives and autism. This is a helpful reference point for all health visitors. Increasing 
uptake of vaccinations via our advocacy role, both for the public and for our own 
professional colleagues is also important. Increased uptake of vaccinations is directly related 
to immunisation effectiveness. Each year immunisation averts an estimated 2-3 million 
deaths globally (WHO 2017d) thus preventing avoidable infections via vaccination is crucial 
to avoiding the unnecessary infections and subsequent use of antimicrobials and antivirals. 
This can be evidenced in a retrospective observational study which assessed the impact of 
Objective Rotavirus (OR) vaccination on paediatric hospital admissions in Lothian. In the two 
years following the vaccine introduction, the annual number of RV gastroenteritis 
admissions fell by 84.7%, bed days reduced by 91.1% and suspected hospital acquired 
infections reduced by 95.7% (Forrest et al 2016). 
In the Public Health England (PHE) (2016) framework for personalised care and population 
health for Nurses, Midwives, Health Visitors and Allied Health Professionals, the focus is on 
‘Making Every Contact Count’. This points to the role of health visitors working with the 
public, in providing opportunistic and timely advice on health to patients/service users, their 
carers, staff and communities with which they come into contact. Therefore, a key action for 
health visitors is to promote and provide immunisations to protect individual, community 
and population health from diseases and therein avoid the need for antibiotics and 
antivirals and contain AMR. 
 
Action area 2: Optimising prescribing practice 
Health visitors have a clear role in the safe management of medicines and can also act as 
advocates, antibiotic guardians (PHE 2017) and advisors with every contact, reinforcing the 
public health message of ‘you don’t need antibiotics for coughs and colds’, and where 
antibiotics are needed; reinforcing the importance of completing the course, not sharing 
them with others and disposing of unused medication appropriately.  
Health visitors are also prescribers and whilst this is well regulated, in the UK and many 
other countries, results of a national survey of health visitors’ prescribing practice revealed 
variations in practice and support (Bishop and Gilroy 2015).  Recommendations included the 
need to re-engage health visitors with how prescribing skills can deliver better outcomes for 
children, families and communities. This seems particularly important for antimicrobial 
prescribing and yet little is known about the prescribing practices of community nurses and 
health visitors with respect to antimicrobials. A Scottish study (Ness et al 2015) was the first 
to examine this issue and found that there has been a steady increase in the amount of 
antimicrobial prescribing in primary care undertaken by nurse prescribers. Evidence 
suggests that nurse prescribers give more advice about self-management, have longer 
consultations and provide more information to patients (RCN 2012). Therefore, health 
visitor prescribers are in an ideal position to educate their clients, even if they themselves 
rarely prescribe antimicrobials, about the differences between viral and bacterial infections 
and how to self-manage their symptoms. If an antimicrobial is necessary then selection of 
the most appropriate one, along with patient education about how to take them properly, is 
a key part of this role.  
 
 
Action area 3: Improving professional education and public engagement 
In a WHO multi-country public awareness survey about AMR (WHO 2015a), levels of 
awareness and understanding around the issues and how to address them were mixed. 
Participants recognised the problem but did not fully understand what caused it or what to 
do about it. Another WHO report also found a lack of awareness within health care workers 
(WHO 2015b) and so it could be argued that awareness raising is necessary for the public 
and for healthcare workers who are not specialists in IPC. 
Understandably when an illness occurs, be it an upper respiratory tract infection in an 
individual in the community, or an outbreak in a school, parents and the public at large may 
wish to ask their General Practitioner for antibiotics as a solution. Research, from medical 
and nursing literature suggests that managing patient expectations about antibiotics can be 
challenging for healthcare professionals (Mustafa et al 2014). All healthcare professionals 
have a responsibility to ensure there is an understanding of when it is appropriate to use 
antibiotics and when it is not (National Institute for Health and Care Excellence (NICE) 2017). 
Health visitors have a unique connection with parents and children in early years, and an 
opportunity therein to influence the public. In this way, we will help develop a new 
generation who understand about the use of antibiotics and can help tackle the global AMR 
challenge. 
To support this education in the early years there are excellent, free teaching resources, 
endorsed by NICE and produced by Public Health England, called e-Bug (e-Bug 2017). This 
educational software package can be used to help children and young people understand 
how infections spread and how antimicrobial resistance develops. Reinforcement of key 
messages through the pre- and school-aged years will support long-term behaviour change. 
With the challenges of health visitor workload it may be that this role is better suited to 
those working within the nursery setting and therefore health visitors, who have links to 
nurseries, may be able to encourage their nursery colleagues to engage in this important 
education. 
Professional education and development is also important. Recommendations, again from a 
recent UK survey of health visitors (Bishop and Gilroy 2015), pointed to the necessity to 
develop consistent, high-quality continuing professional development (CPD) around 
prescribing for health visitors. There also needs to be a focus on antibiotic stewardship and 
IPC practice in this regard. 
Conclusion 
AMR is a major public health threat worldwide and there is an international call to action for 
all disciplines to engage in playing their part in this important agenda. The health visitor 
contribution to this agenda is threefold: in improving infection prevention and control in 
human health, antibiotic stewardship and prescribing, and in improving public engagement 
and professional development in antibiotic stewardship and IPC. By focussing on these 
actions health visitors can ensure they maximise their contribution to containing AMR. 
 
Key points 
 AMR has been referred to as one of the greatest threats to public health with a 
projected attributable mortality of 50 million people a year globally by 2050   
 The health visitor contribution to this agenda is threefold: in improving infection 
prevention and control in human health, antibiotic stewardship and prescribing, and 
in improving public engagement and professional development in antibiotic 
stewardship and IPC.  
 Our IPC contribution involves maximising the potential uptake of vaccinations and 
infection control precautions to prevent the infections in the first place, hence 
negating the need for unnecessary antibiotics  
 Consistent, high-quality public engagement and education, and continuing 
professional development (CPD) around prescribing for health visitors is needed with 
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Table 1: WHO priority pathogens list for R&D of new antibiotics 
Priority 1: Critical  Acinetobacter baumannii, carbapenem-resistant 
 Pseudomonas aeruginosa, carbapenem-resistant 
 Enterobacteriaceae, carbapenem-resistant, ESBL-producing 
Priority 2: High  Enterococcus faecium, vancomycin-resistant 
 Staphylococcus aureus, methicillin-resistant, vancomycin-
intermediate and resistant 
 Helicobacter pylori, clarithromycin-resistant 
 Campylobacter spp., fluoroquinolone-resistant 
 Salmonellae, fluoroquinolone-resistant 
 Neisseria gonorrhoeae, cephalosporin-resistant, 
fluoroquinolone-resistant 
Priority 3: Medium  Streptococcus pneumoniae, penicillin-non-susceptible 
 Haemophilus influenzae, ampicillin-resistant 
 Shigella spp., fluoroquinolone-resistant 
 
 
Table 2: The 7 key areas for future action from the UK AMR Strategy 
1 Improving infection prevention and control practices in human and animal health 
2 Optimising prescribing practice 
3 Improving professional education, training and public engagement 
4 Developing new drugs, treatments and diagnostics 
5 Better access to, and use of, surveillance data in human and animal sectors 
6 Better identification and prioritisation of AMR research needs 
7 Strengthened international collaboration 
 
